Del Global Technologies Corp. Completes Purchase of 80% of Villa Sistemi Medicali S.p.A. and Adds Important New Medical Lines to Product Mix.

Business Editors

VALHALLA, N.Y.--(BUSINESS WIRE)--April 25, 2000

Del Global Technologies Corp. (NASDAQ: DGTC), a leading independent producer of medical imaging and diagnostic systems, announced today that it has exercised a previously disclosed option to increase its ownership interest to 80% in Villa Sistemi Medicali S.p.A., of Milan, Italy, thus adding an important new European dimension to the Company's expanding activities.

"This acquisition not only broadens our product line of medical imaging systems, but also provides Del Global with even more effective representation in Europe," said Leonard A. Trugman, Del's Chairman, CEO and President. "Our Company's consolidated revenues on an annualized basis will now be approximately $100 million, and we expect Villa, as with other Del Global acquisitions, to make a significant contribution to the Company's continued growth."

Del Global announced in January the acquisition of a 19% equity stake in Villa, along with an exclusive irrevocable option to increase its ownership interest to 80%.

Villa, with annual sales of approximately $20 million, has leading edge radiographic/fluoroscopic (R/F) technology. It manufactures a full line of R/F systems, including remote control features, as well as a line of portable imaging systems with power ratings up to 30kW, which is complementary to Del's existing line. In addition, Villa produces a comprehensive line of dental imaging systems, consisting of intraoral and panoramic systems, which will bring a new imaging application to Del Global.

"Besides giving Del Global a truly global presence, the acquisition of Villa opens new avenues of growth for our Company. Approximately 25% of Villa's sales are derived from the Italian market with very little except dental in the U.S." said Mr. Trugman.

"This acquisition should result in further sales and earnings growth due to the synergies of our expanded product lines and cross-marketing programs," Mr. Trugman concluded.

Del Global Technologies Corp. is primarily engaged in the design, manufacture and marketing of state-of-the-art, cost-effective medical imaging and diagnostic systems consisting of stationary and portable imaging systems, radiographic/fluoroscopic systems, mammography systems, Neo-Natal systems, dental imaging systems and proprietary precision power conversion subsystems for medical as well as critical industrial applications. These include airport explosives detection, electronic noise suppression subsystems, analytical instrumentation, semiconductor capital equipment and energy exploration.

This press release contains forward-looking statements. Such statements involve various risks that may cause actual results to differ materially. These risks include, but are not limited to, the ability of the Company to grow internally or by acquisition and to integrate acquired businesses, changing industry and competitive conditions, and other risks referred to in the Company's registration statements and periodic reports filled with the Securities & Exchange Commission.